BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19283412)

  • 41. Screening for anxiety and depression in cancer patients: the effects of disease and treatment.
    Ibbotson T; Maguire P; Selby P; Priestman T; Wallace L
    Eur J Cancer; 1994; 30A(1):37-40. PubMed ID: 8142161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psychometric properties of the Hospital Anxiety and Depression Scale in an inpatient video-monitoring epilepsy cohort.
    McCartney L; Johnstone B; O'Brien T; Kwan P; Kalincik T; Velakoulis D; Malpas C
    Epilepsy Behav; 2020 Feb; 103(Pt A):106631. PubMed ID: 31870806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative validity of depression assessment scales for screening poststroke depression.
    Kang HJ; Stewart R; Kim JM; Jang JE; Kim SY; Bae KY; Kim SW; Shin IS; Park MS; Cho KH; Yoon JS
    J Affect Disord; 2013 May; 147(1-3):186-91. PubMed ID: 23167974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales].
    Lobo A; Chamorro L; Luque A; Dal-Ré R; Badia X; Baró E;
    Med Clin (Barc); 2002 Apr; 118(13):493-9. PubMed ID: 11975886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validity and screening properties of three depression rating scales in a prospective sample of patients with severe traumatic brain injury.
    Schwarzbold ML; Diaz AP; Nunes JC; Sousa DS; Hohl A; Guarnieri R; Linhares MN; Walz R
    Braz J Psychiatry; 2014 Sep; 36(3):206-12. PubMed ID: 24770656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hospital anxiety and depression scale cutoff scores for cancer patients in acute care.
    Singer S; Kuhnt S; Götze H; Hauss J; Hinz A; Liebmann A; Krauss O; Lehmann A; Schwarz R
    Br J Cancer; 2009 Mar; 100(6):908-12. PubMed ID: 19240713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of the Arabic version of the MADRS scale among Lebanese patients with depression.
    Hallit S; Obeid S; El Hage W; Kazour F
    Encephale; 2019 Jun; 45(3):195-199. PubMed ID: 30122299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Basic Documentation for Psycho-Oncology Short Form (PO-Bado SF)--an expert rating scale for distress screening: development and psychometric properties.
    Marten-Mittag B; Book K; Buchhold B; Dinkel A; Gründobler B; Henrich G; Huber B; Pirker C; Regenberg A; Schickel S; Senf B; Wünsch A; Herschbach P
    Psychooncology; 2015 Jun; 24(6):653-60. PubMed ID: 25346529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA).
    Takahashi N; Tomita K; Higuchi T; Inada T
    Hum Psychopharmacol; 2004 Apr; 19(3):187-92. PubMed ID: 15079853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validating screening tools for depression in stroke and transient ischemic attack patients.
    Prisnie JC; Fiest KM; Coutts SB; Patten SB; Atta CA; Blaikie L; Bulloch AG; Demchuk A; Hill MD; Smith EE; Jetté N
    Int J Psychiatry Med; 2016 Apr; 51(3):262-77. PubMed ID: 27284119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inter-rater reliability among psychiatrists when assessing depression according to the Montgomery-Åsberg Depression Rating Scale.
    Geijer J; Baigi A; Aiff H
    Nord J Psychiatry; 2021 Nov; 75(8):607-613. PubMed ID: 34156321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A three-tier process for screening depression and anxiety among children and adolescents with cancer.
    Yardeni M; Abebe Campino G; Bursztyn S; Shamir A; Mekori-Domachevsky E; Toren A; Gothelf D
    Psychooncology; 2020 Dec; 29(12):2019-2027. PubMed ID: 32691478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction.
    Strik JJ; Honig A; Lousberg R; Denollet J
    Psychosomatics; 2001; 42(5):423-8. PubMed ID: 11739910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detecting depressive and anxiety disorders in distressed patients in primary care; comparative diagnostic accuracy of the Four-Dimensional Symptom Questionnaire (4DSQ) and the Hospital Anxiety and Depression Scale (HADS).
    Terluin B; Brouwers EP; van Marwijk HW; Verhaak P; van der Horst HE
    BMC Fam Pract; 2009 Aug; 10():58. PubMed ID: 19698153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometer.
    Dolbeault S; Bredart A; Mignot V; Hardy P; Gauvain-Piquard A; Mandereau L; Asselain B; Medioni J
    Palliat Support Care; 2008 Jun; 6(2):107-17. PubMed ID: 18501045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic accuracy of the Montgomery-Åsberg Depression Rating Scale parent report among adolescent psychiatric outpatients.
    Torres Soler C; Olofsdotter S; Vadlin S; Ramklint M; Nilsson KW; Sonnby K
    Nord J Psychiatry; 2018 Apr; 72(3):184-190. PubMed ID: 29258381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recognizing depression in patients with Parkinson's disease: accuracy and specificity of two depression rating scale.
    Silberman CD; Laks J; Capitão CF; Rodrigues CS; Moreira I; Engelhardt E
    Arq Neuropsiquiatr; 2006 Jun; 64(2B):407-11. PubMed ID: 16917610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.
    Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A
    BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 'Optimal' cutoff selection in studies of depression screening tool accuracy using the PHQ-9, EPDS, or HADS-D: A meta-research study.
    Brehaut E; Neupane D; Levis B; Wu Y; Sun Y; Ioannidis JPA; Markham S; Cuijpers P; Patten SB; Benedetti A; Thombs BD
    Int J Methods Psychiatr Res; 2023 Sep; 32(3):e1956. PubMed ID: 36461893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic Validity and Factor Analysis of Montgomery-Asberg Depression Rating Scale in Parkinson Disease Population.
    Ketharanathan T; Hanwella R; Weerasundera R; de Silva VA
    J Geriatr Psychiatry Neurol; 2016 May; 29(3):115-9. PubMed ID: 26392481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.